If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
MOUNJARO tirzepatide 10 mg/0.5 mL solution for injection vial AUST R: 407053Active ingredients:
tirzepatide
Dosage form:
Injection, solution
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
1800 454 559
|
Deletion from market:
13 Jun 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by ARTG 439692 - MOUNJARO KwikPen tirzepatide 16.67 mg/mL solution for injection multidose pre-filled pen. More information about this discontinuation is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/discontinuation-mounjaro-tirzepatide-vials
|
MOUNJARO tirzepatide 12.5 mg/0.5 mL solution for injection vial AUST R: 407052Active ingredients:
tirzepatide
Dosage form:
Injection, solution
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
1800 454 559
|
Deletion from market:
13 Jun 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by ARTG 439693 - MOUNJARO KwikPen tirzepatide 20.83 mg/mL solution for injection multidose pre-filled pen. More information about this discontinuation is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/discontinuation-mounjaro-tirzepatide-vials
|
MOUNJARO tirzepatide 15 mg/0.5 mL solution for injection vial AUST R: 407054Active ingredients:
tirzepatide
Dosage form:
Injection, solution
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
1800 454 559
|
Deletion from market:
13 Jun 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by ARTG 439694 - MOUNJARO KwikPen tirzepatide 25 mg/mL solution for injection multidose prefilled pen. More information about this discontinuation is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/discontinuation-mounjaro-tirzepatide-vials
|
MOUNJARO tirzepatide 2.5 mg/0.5 mL solution for injection vial AUST R: 407055Active ingredients:
tirzepatide
Dosage form:
Injection, solution
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
1800 454 559
|
Deletion from market:
13 Jun 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by ARTG 439430 - MOUNJARO KwikPen tirzepatide 4.17 mg/mL solution for injection multidose pre-filled pen. More information about this discontinuation is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/discontinuation-mounjaro-tirzepatide-vials
|
MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial AUST R: 407050Active ingredients:
tirzepatide
Dosage form:
Injection, solution
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
1800 454 559
|
Deletion from market:
13 Jun 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by ARTG 439690 - MOUNJARO KwikPen tirzepatide 8.33 mg/mL solution for injection multidose pre-filled pen. More information about this discontinuation is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/discontinuation-mounjaro-tirzepatide-vials
|
MOUNJARO tirzepatide 7.5 mg/0.5 mL solution for injection vial AUST R: 407051Active ingredients:
tirzepatide
Dosage form:
Injection, solution
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
1800 454 559
|
Deletion from market:
13 Jun 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by ARTG 439691 - MOUNJARO KwikPen tirzepatide 12.5 mg/mL solution for injection multidose pre-filled pen. More information about this discontinuation is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/discontinuation-mounjaro-tirzepatide-vials
|